- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00698074
Diastolic Ventricular Interaction and the Effects of Biventricular Pacing in Hypertrophic Cardiomyopathy
June 13, 2008 updated by: University Hospital Birmingham
The primary aim of this study will be to assess whether Biventricular pacing improves exercise capacity, and Quality of Life in patients with symptomatic drug resistant Non-Obstructive Hypertrophic Cardiomyopathy, using a Biventricular pacemaker.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
32
Phase
- Phase 3
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Michael P Frenneaux, MBBS
- Phone Number: 5916 121-414-5916
- Email: m.p.frenneaux@bham.ac.uk
Study Locations
-
-
West Midlands
-
Birmingham, West Midlands, United Kingdom, B15 2TT
- Recruiting
- Department Cardiovascular Medicine, University of Birmingham
-
Contact:
- ibrar ahmed, MBChB
- Phone Number: 121-414-5916
- Email: 01ahmedi@gmail.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Symptomatic Hypertrophic Cardiomyopathy,
Exclusion Criteria:
- Rhythm other than normal sinus Left ventricular outflow tract gradient greater than 30mmHg Inability to exercise v02 max greater than 70% of predicted.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: CROSSOVER
- Masking: DOUBLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: 1
Cardiac Resynchronisation Therapy
|
Biventricular Pacemaker Implant
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Registration Dates
First Submitted
June 11, 2008
First Submitted That Met QC Criteria
June 13, 2008
First Posted (ESTIMATE)
June 16, 2008
Study Record Updates
Last Update Posted (ESTIMATE)
June 16, 2008
Last Update Submitted That Met QC Criteria
June 13, 2008
Last Verified
June 1, 2008
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 05/Q2709/64
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypertrophic Cardiomyopathy
-
French Cardiology SocietyCompleted1- Primary (Sarcomeric) Hypertrophic Cardiomyopathy | 2- Obstructive Hypertrophic Cardiomyopathy | 3- Non Obstructive Hypertrophic CardiomyopathyFrance
-
University of Sao PauloCompletedNon-obstructive Hypertrophic Cardiomyopathy | Obstructive Hypertrophic CardiomyopathyBrazil
-
Montreal Heart InstituteCanadian Institutes of Health Research (CIHR)Enrolling by invitationCardiomyopathies | Hypertrophic Cardiomyopathy | Hypertrophic Obstructive Cardiomyopathy | Familial Hypertrophic CardiomyopathyCanada
-
Bristol-Myers SquibbActive, not recruitingHypertrophic Cardiomyopathy | Non-obstructive Hypertrophic Cardiomyopathy | Obstructive Hypertrophic CardiomyopathyDenmark, United States, Belgium, Czechia, France, Germany, Israel, Italy, Netherlands, Poland, Portugal, Spain, United Kingdom
-
Yonsei UniversityCompletedFamilial Hypertrophic CardiomyopathyKorea, Republic of
-
Hangzhou Valgen Medtech Co., LtdNot yet recruitingObstructive Hypertrophic CardiomyopathyChina
-
China National Center for Cardiovascular DiseasesNot yet recruitingObstructive Hypertrophic Cardiomyopathy
-
Bristol-Myers SquibbNot yet recruitingObstructive Hypertrophic CardiomyopathyKorea, Republic of
-
Ji Xing Pharmaceuticals (Shanghai) Co., Ltd.RecruitingObstructive Hypertrophic CardiomyopathyChina
-
Xiang WeiRecruitingNonobstructive Hypertrophic CardiomyopathyChina
Clinical Trials on Cardiac Resynchronisation Therapy
-
Guy's and St Thomas' NHS Foundation TrustUnknownHeart FailureUnited Kingdom
-
University Hospitals Coventry and Warwickshire...MedtronicUnknownChronic Heart FailureUnited Kingdom
-
University of LeedsCompletedLeft Ventricular Function Systolic DysfunctionUnited Kingdom
-
University Hospital, Clermont-FerrandGeneral Electrics FranceUnknown
-
University of RzeszowCompletedChronic Kidney Diseases | Chronic Heart Failure
-
Biotronik SE & Co. KGCompletedHeart Failure, CongestiveGermany, Israel, Netherlands, Czech Republic, United Kingdom, France, Austria, Italy, Latvia, Spain
-
Universitaire Ziekenhuizen KU LeuvenOslo University HospitalActive, not recruitingHeart Failure | Cardiomyopathy | Left Ventricular Dyssynchrony | Left Bundle Branch BlockBelgium, Norway
-
Guy's and St Thomas' NHS Foundation TrustNational Institute for Health Research, United KingdomCompleted
-
The Leeds Teaching Hospitals NHS TrustCompletedArrhythmiasUnited Kingdom
-
Cardiff and Vale University Health BoardAbbott Medical DevicesWithdrawnHeart Failure, SystolicUnited Kingdom